NV40:FRA
Cellectar Biosciences Inc
0,25 €
0,00%
(0,00) 1D
24-июн., 08:08:19 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Investing News Network
·
42 мүнөт мурун
Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia
Investing.com Canada
·
2 саат мурун
Cellectar reports trial data for cancer drug in rare disease By Investing.com
Stock Titan
·
2 саат мурун
Cancer treatment responses lasted a median 16 months in Cellectar's study